Suchergebnisse - "Magro, F"

PubPharm (7)

1

Reintroduction of Anti-TNFα Therapy After (or even During) Anti-TNFα-associated Tuberculosis in Immune-mediated Diseases

enthalten in: Journal of Crohn's & colitis | 2016

von Abreu, C. | Sarmento, A. | Magro, F.

2

Case series : ulcerative colitis, multiple sclerosis, and interferon-beta 1a

enthalten in: Inflammatory bowel diseases | 2010

von Rodrigues, S. | Magro, F. | Soares, J. | +5

3

Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis

enthalten in: Inflammatory bowel diseases | 2008

von Marques, M. | Magro, F. | Cardoso, H. | +4

CommentIn: Inflamm Bowel Dis. 2011 Nov;17(11):E149-50. - PMID 21987301

4

Infliximab dose intensification by shortening infusion intervals

enthalten in: Inflammatory bowel diseases | 2008

von Magro, F. | Bastos, R. | Marques, M. | +1

5

Long-standing remission of Crohn's disease under imatinib therapy in a patient with Crohn's disease

enthalten in: Inflammatory bowel diseases | 2006

von Magro, F. | Costa, C.

CommentIn: Inflamm Bowel Dis. 2008 Apr;14(4):579-81. - PMID 18050299

6

Unusual presentation of tuberculosis after infliximab therapy

enthalten in: Inflammatory bowel diseases | 2005

von Magro, F. | Pereira, P. | Veloso, F. | +1

7

Reactive hepatitis in a patient with Crohn's disease successfully treated with infliximab : does tumor necrosis factor alpha play a role in reactive hepatitis?

enthalten in: Inflammatory bowel diseases | 2005

von Magro, F. | Pereira, P. | Carneiro, F. | +1

1
[1]